December 02, 2016
Our Commitment to the Most Common Adult Leukemia
Learn more about the symptoms and treatment of chronic lymphocytic leukemia (CLL).

This weekend, AbbVie joins more than 20,000 hematology professionals for the world’s premiere event in hematology, the American Society of Hematology (ASH) Annual Meeting to share new research in the most common form of adult leukemia, chronic lymphocytic leukemia (CLL). 

CLL is a slow-growing type of cancer that most commonly arises from B cells, a type of white blood cell (called lymphocytes) that originates in the bone marrow. 1 The cancer (leukemia) cells start in the bone marrow but then go into the blood. These cells crowd out healthy blood cells and make it difficult for the body to fight infection.1 

CLL is more prevalent in men and mainly affects older adults. It’s estimated that 115,000 patients in the United States live with this blood cancer, with approximately 19,000 newly diagnosed patients every year.

Discover more about this disease, common symptoms and treatment below.


1American Cancer Society. Leukemia – What is CLL. Available from: Accessed November 2016.
2IMS Database [Data on File]
3 American Cancer Society. What are the key statistics for chronic lymphocytic leukemia? Available from: Accessed November 2016.

Media inquiries:

Kelli Teno
Call: +1 847-935-9593



The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?